MedTrace Logo

Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.

NCT04543175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2020-09-10

No results posted yet for this study

Summary

Taste disorders in cancer patients during chemotherapy could be consider as multifactorial disease, it is related with changes of food consumption. Approximately 36-69% of the patients under chemotherapy suffer oral toxicity or dysgeusia

A prospective case- only observational study was conducted in patients of the Hospital General de México for two years. A self-reported taste survey was used, and patients scored their results in a Likert scale.

Conditions

  • Breast Cancer
  • Taste Disorders
  • Dysgeusia
  • Ageusia
  • Quality of Life

Interventions

OTHER

Taste disorder´s test

Each patient performed their own test placing three drops with a disposable dropper from each bottle into the center of the tongue for whole-mouth testing.

Sponsors & Collaborators

  • Hospital General de Mexico

    lead OTHER_GOV

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-01-01
Completion
2019-01-01

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04543175 on ClinicalTrials.gov